Perception Neuroscience is developing PCN-101 (Arketamine, or R-ketamine) with a vision of providing significantly improved solutions to serious mental health disorders.
Location: United States, New York
Employees: 1-10
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | Subversive | subversive... |